Some individuals maintain mental sharpness even when their brains show the biological changes linked to Alzheimer’s disease. A recent study from the Netherlands Institute for Neuroscience suggests that the key may lie in the response of a rare kind of brain cell known as immature neurons to damage. These insights shed light on cognitive resilience, illustrating the brain’s ability to keep functioning despite disease.
A significant question in Alzheimer’s research remains: why does the disease impact people so differently? While many experience memory loss and dementia as Alzheimer’s progresses, there are others who exhibit little to no cognitive decline, despite sharing similar brain pathology.
“Approximately 30 percent of older adults who develop Alzheimer’s disease never show symptoms,” states senior author Evgenia Salta. “We’re still in the dark about why that is. It’s a substantial mystery and a crucial one.”
Discovering what protects these individuals could ultimately guide scientists toward innovative treatments or preventive measures for dementia.
“Understanding the protective factors in these brains could lead to new therapeutic strategies.”
Can aging brains regenerate damaged cells?
One hypothesis suggests that resilient brains are simply better at self-repair.
“Perhaps they can generate new brain cells to compensate for those that are deteriorating,” Salta proposes.
This notion revolves around adult neurogenesis, which is the creation of new neurons in the adult brain. Although this phenomenon is well-documented in various animal species, scientists have long debated the extent, if any, to which it occurs in humans.
To explore this, Salta and her team examined brain tissue samples from the Netherlands Brain Bank. The samples included healthy individuals, those afflicted with Alzheimer’s disease, and individuals whose brains displayed Alzheimer’s pathology without ever developing dementia.
The researchers focused on a small area within the brain’s memory center, one of the few sites where new neurons might still emerge.
“These cells are quite rare, so we had to devise new techniques to locate them,” Salta explains. “We honed in on the exact area where we anticipated finding them.”
The team also employed newly created analytical methods specifically tailored for human tissue, minimizing dependence on assumptions drawn from animal research.
Rare immature neurons continue into old age
The researchers successfully identified the cells they were looking for: immature neurons, resembling young neurons that haven’t fully matured.
“Even at an average age above 80, we discovered these immature neurons across all groups,” Salta notes.
This result confirmed that these unique cells persist even in very elderly brains.
However, what surprised the researchers was that resilient individuals didn’t have significantly higher counts of immature neurons compared to those with Alzheimer’s disease.
Cell behavior might outweigh quantity
Instead, the key difference seemed to be how the cells were functioning.
“In resilient individuals, these cells appear to activate survival programs that help them withstand and manage damage,” Salta comments. “We also observed reduced signs of inflammation and cell death.”
The findings imply that these immature neurons might do more than just offset cell loss during disease.
“It may not be solely about replacing lost neurons,” Salta clarifies. “These cells could possibly assist in supporting the surrounding tissue, helping the brain remain functional and ‘youthful.’ They might act like fertilizer in a garden that’s falling apart.”
Nonetheless, Salta cautions that these concepts are still hypothetical. Since this study relied on donated brain tissue, the researchers couldn’t directly observe how the cells operate in living brains.
“We infer the cells’ function based on the data, but we can’t verify it in this type of study,” she adds.
She also stresses that the factors contributing to Alzheimer’s resilience are likely multifaceted.
“This is merely one piece of a much larger puzzle,” she concludes. “There’s unlikely to be a single factor that clarifies resilience.”
A new trajectory for Alzheimer’s research
This study raises broader questions regarding aging itself.
“Along this path, there’s some kind of decision point,” Salta elaborates. “Some individuals maintain stability, while others develop dementia. We aim to understand what drives that variance.”
Future research will delve into how immature neurons interact with other brain cells and whether these interactions aid in retaining memory and cognitive function.
While this study doesn’t clarify why the behaviors of these cells differ in resilient individuals as opposed to those who develop dementia, it signifies a shifting focus in Alzheimer’s research. Researchers are increasingly interested in understanding not just how the disease harms the brain, but why some brains can endure such damage.
“Cognitive resilience is incredibly fascinating,” Salta remarks. “If we grasp the protective factors in these brains, it could eventually lead to innovative treatment strategies.”
For the moment, these findings contribute to a growing body of evidence indicating that the aging brain is more adaptable and intricate than researchers previously believed.
